Sonic Foundry explores capital options ( Madison Wis.

Sonic Foundry explores capital options

Madison, Wis. - Rich media developer Sonic Foundry, Inc. has exceeded the $75 million market capitalization mark, a milestone that has enabled it to access what CEO Rimas Buinevicius called an orderly equity-raising process.

Sonic Foundry has set this process in motion with a

Source:wistechnology.com By Chris Fleissner 11/20/06

Page: 1 2
Related biology technology :

1. Sonic Foundry reports GAAP loss as Q2 revenues rise
2. Sonic Foundry upgrades Mediasite for podcasts
3. Sonic Foundry reports net loss, higher revenue
4. New Sonic Foundry search engine finds words, phrases in video presentations
5. Sonic Foundry completes $11.25M stock offer
6. Sonic Foundry sets $3.75 stock price
7. Sonic Foundry reports first cash-positive quarter
8. Visions: Rimas Buinevicius, CEO of Sonic Foundry
9. Sonic closer to turning profit corner
10. Sonic Foundry offers Mediasite to military families
11. Sonic Foundrys Mediasite moves to podcasts

Post Your Comments:

(Date:11/23/2009)...v. 23, 2009 In a provocative new study, a Univers...oxide emissions the major cause of global warming...collapses or society builds the equivalent of one ...nlikely that there will be any substantial near-te...n carbon dioxide emission rates," says the new pap...

(Date:11/23/2009)...romises ultra-fast communication, computation and ...n. But trying to use quantum states as carriers of...w two physicists have shown, mathematically, how t...nication, while keeping the information intact. Th...ical Review Letters and highlighted with a Viewpo...

(Date:11/23/2009)...E,Nev.,Nov.23/PRNewswire-FirstCall/--PDLBioPharma,...sestablishedNovember27,2009astheex-dividenddatefor...ngfromthesecuritizationtransactioncompletedonNovem...allstockholdersofrecordontherecorddate,December1,2...ividendat$1.67pershareofcommonstockforpurposesofth...

(Date:11/23/2009)...,Nov.23/PRNewswire-FirstCall/--NeogenCorporation(N....D.,waselectedtoNeogen,sBoardofDirectorsatthecompa...erhasmorethan40yearsofexperienceinthefood,agricult...tprofessorofagriculturaleconomicsatVirginiaTechUni...edStateschiefagriculturenegotiatorwiththerankofamb...

Breaking Biology Technology:Is global warming unstoppable? 2 Is global warming unstoppable? 3 Is global warming unstoppable? 4 PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2 Richard T. Crowder Joins Neogen's Board of Directors 2

[0] Is global warming unstoppable?[0] Straightening messy correlations with a quantum comb [0] PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend [0] Richard T. Crowder Joins Neogen's Board of Directors

...ific (NYSE: BSX ) today announced special items ...uarter. The Company plans to release its first qu...ompany disclosed last month, the Court of Appeals ...s decision that Johnson & Johnson,s (J&J) ...e Boston Scientific,s patent and that the patent i...

...gnostics,Incorporated (NYSE: DGX ) today announc...osed federal government investigation related to c...anufacturing subsidiary closed,voluntarily in 2006... since,its investigation began in 2004. , Ques...civil investigation.,While the company disagrees w...

...announced today that it,has completed the formatio...ment its existing group of Senior Advisers. NexBi... of DAS181 (Fludase(R)), an investigational drug,c...Bio throughout the clinical,development of this no...ced,product development to address the threat of a...

Other Biology Technology:Boston Scientific Announces First Quarter Special Items 2 Boston Scientific Announces First Quarter Special Items 3 Boston Scientific Announces First Quarter Special Items 4 Boston Scientific Announces First Quarter Special Items 5 Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006 2 NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 2 NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 3 NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 4

Boston Scientific Announces First Quarter Special Items Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006 NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza

(Date:11/24/2009)...t keep weakened and flabby arteries from collapsin..., those stents are no longer needed -- once the ar...Previously, doctors had no choice but to leave the... University,s Department of Biomedical Engineering... that carries drugs where they,re needed, then dis...

(Date:11/24/2009)...UGE Antarctica has long held secrets of the earth...ently, there has been very little information on t...s of ice for millions of years. Now, a team of res...ve been funded to the tune of $10 million dollars ... to the bottom of things literally. These scienti...

(Date:11/23/2009)...New research presents strong evidence that the "sy...utdoor traffic-related pollution and indoor endoto...or the other exposure alone. , Environmental h...UC) College of Medicine have shown that children e...icles and indoor endotoxin during early life are s...

Breaking Biology News(10 mins):A coating for life 2 LSU gets to the bottom of things -- in Antarctica 2 Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2 Prostate cancer gives a new outlook on life 58853 1 Prostate cancer gives a new outlook on life 58853 2 University of Washington receives 2425 million to create Northwest Genomics Center 10256 1 University of Washington receives 2425 million to create Northwest Genomics Center 10256 2 University of Washington receives 2425 million to create Northwest Genomics Center 10256 3 University of Washington receives 2425 million to create Northwest Genomics Center 10256 4 Focused Radiation Protects Tumor Patients Brain Function 58850 1 Focused Radiation Protects Tumor Patients Brain Function 58850 2

[0] A coating for life [0] LSU gets to the bottom of things -- in Antarctica [0] Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later

... in response to higher global temperatures may be ...count plants, ability to adjust to changing condit...onal Laboratory. , In a Perspectives paper publish...tes ORNL findings suggesting that about 9 percent ... the acclimation of plants included in the model. ...

...bage-eating moth may one day provide a safer, targ...y, researchers say. , , They compared the abilit... transposons, to insert themselves into a cell,s D...e cell resistant to damage from radiation therapy....o 10 times better than the other circular pieces o...

...nia, Los Angeles have defined conditions associate...n almost a third of breast cancer survivors, accor...ncer Research. , The key to their fatigue stems ...hese studies identify a biological basis for persi...ted by inflammation," said Michael Irwin, M.D., di...

Other Biology News:Plants' role in global warming re-examined 2 Jumping gene could provide non-viral alternative for gene therapy 2 Jumping gene could provide non-viral alternative for gene therapy 3 Inflammation markers identify fatigue in breast cancer survivors 2

Plants' role in global warming re-examined Jumping gene could provide non-viral alternative for gene therapy Inflammation markers identify fatigue in breast cancer survivors

EDTA Solution (pH 8.0) (0.5 M) from BioVision

Rat Anti-Mouse Limitin Monoclonal Antibody, Unconjugated, Clone 183727 from R&D Systems

Normal Human Serum from CHEMICON

Human HGF, Unconjugated from R&D Systems

Biology Products:

EDTA Solution (pH 8.0) (0.5 M) from BioVision Rat Anti-Mouse Limitin Monoclonal Antibody, Unconjugated, Clone 183727 from R&D Systems Normal Human Serum from CHEMICON Human HGF, Unconjugated from R&D Systems

( Madison Wis. - Rich media developer ...)Sonic Foundry explores capital options